View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/HRSA | RIN: 0906-AA94 | Publication ID: Spring 2013 |
Title: 340B Orphan Drug Exclusion | |
Abstract: This final rule provides clarity on orphan drug exclusions for covered entities under the 340B Program. | |
Agency: Department of Health and Human Services(HHS) | Priority: Info./Admin./Other |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 42 CFR 10 | |
Legal Authority: 340B PHS Act (42 USC 256b), as amended sec 215 PHS Act (42 USC 216), as amended sec 526 FFDC Act (21 USC 360bb) sec 701(a) FFDC Act (21 USC 371(a) |
Legal Deadline:
None |
||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Bradford Lang Public Health Analyst/Health Care System Bureau Department of Health and Human Services Health Resources and Services Administration 5600 Fishers Lane, Room 10C-03, Rockville, MD 20857 Phone:301 443-2671 Fax:301 594-4982 Email: blang@hrsa.gov |